The Blanket Purchase Agreement (BPA) contract awarded to Immucor Inc. by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) is intended to provide a reliable supply of critical medical supplies related to blood transfusion and transplantation testing. Immucor, a leading manufacturer of in vitro diagnostic reagents, instruments, and consumables, will deliver a variety of immunology reagents, test kits, and related products to support the VA's healthcare operations...
This is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 6 to Immucor Inc., a leading provider of automated instrument-reagent systems and consumables for blood transfusion and transplantation compatibility testing. The BPA, valued at $53,174.88, is for the delivery of blood bank reagents and quality control materials to support the VA's blood banking operations. Through this BPA, the VA is procuring essential in vitro...
The Department of Veterans Affairs Veterans Health Administration (VHA) has awarded a Blanket Purchase Agreement (BPA) contract to Immucor Inc., a leading provider of automated instrument-reagent systems and consumables for blood transfusion and transplantation compatibility testing. Under this single-award IDV contract with a $441,379.40 ceiling value, Immucor will deliver blood bank reagents, test kits, and related diagnostic products to support the testing programs and healthcare services...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 (VISN 1) has awarded a Blanket Purchase Agreement (BPA) contract to Immucor Inc., a manufacturer of in vitro diagnostic products and reagents. The BPA, valued at $295,907.80, is issued under Immucor's existing GSA Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. Through a series of BPA call orders, Immucor will provide specialized blood typing, compatibility, and antibody screening...
The Department of Veterans Affairs Veterans Health Administration awarded Immucor Inc. two blanket purchase agreement call contracts under the General Services Administration Federal Supply Schedule Invitro Diagnostics, Reagents, Test schedule. The first BPA call, valued at $17,442, is for blood bank reagents to be provided through November 2024 in Wilkes-Barre, Pennsylvania. The second BPA call, valued at $87,211.70, is for Immucor reagents to be provided through November 2027 also in...
This federal Blanket Purchase Agreement (BPA) with a ceiling value of $100,933.45 was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 to Werfen USA LLC, a for-profit manufacturer of in vitro diagnostic equipment, reagents, and services. The BPA is issued under Werfen's General Services Administration (GSA) Federal Supply Schedule 65-VII contract for in vitro diagnostics, reagents, and test kits. This contract does not have a set-aside designation....
This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Immucor Inc., a manufacturer of blood banking reagents and diagnostic products. The BPA facilitates recurring purchases of Immucor's bulk blood bank reagents on an as-needed basis, as evidenced by the multiple firm-fixed price call orders issued between January 2018 and March 2020 totaling approximately $149,000. Performance takes place at Immucor's location in Norcross, Georgia. The original...
This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 1 (VISN 1) of the U.S. Department of Veterans Affairs (VA) to Werfen USA LLC, a for-profit manufacturer of in vitro diagnostic equipment, reagents, and services. The BPA, valued at up to $300,000.00, is for the provision of blood bank reagents under the VA's GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. The contract has a period of performance from September 15, 2023 through...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 (VISN 17) awarded a Blanket Purchase Agreement (BPA) to Werfen USA LLC, a manufacturer and supplier of in vitro diagnostic equipment, reagents, and services. The $225,000 BPA, awarded on April 1, 2024 with an ultimate completion date of March 31, 2029, is to provide blood bank reagents in support of the VA's blood banking operations and healthcare services. The VA has also awarded two task orders under this BPA to...
The Department of Veterans Affairs Veterans Health Administration awarded a blanket purchase agreement to Immucor Inc. to provide blood bank reagents in support of VISN 4 operations. Three firm fixed price calls were placed against the agreement's GSA Schedule 65-VII contract for in vitro diagnostics and test reagents. The first call, valued at $157,837.38, was issued on October 1, 2023 for a one-year period of performance ending September 30, 2024 in Aspinwall, Pennsylvania. The second call,...